gera Therapeutics
Total Raised
$12.3MInvestors Count
15Funding, Valuation & Revenue
4 Fundings
gera Therapeutics's latest funding round was a Acquired for on July 15, 2011.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/15/2011 | Acquired | |||||
9/10/2009 | Debt | |||||
8/21/1997 | Unattributed | |||||
Other Investors |
Date | 7/15/2011 | 9/10/2009 | 8/21/1997 | |
|---|---|---|---|---|
Round | Acquired | Debt | Unattributed | Other Investors |
Amount | ||||
Investors | ||||
Valuation | ||||
Revenue | ||||
Sources |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
gera Therapeutics Investors
15 Investors
gera Therapeutics has 15 investors. Pharmascience invested in gera Therapeutics's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
7/15/2011 | 7/15/2011 | 1 Acquired | Corporation | Canada | ||
8/21/1997 | 8/21/1997 | 1 Unattributed | Venture Capital | Canada | ||
8/21/1997 | 8/21/1997 | 1 Unattributed | Michael Cross | Venture Capital | Canada | |
Public-Private Partnership | Canada | |||||
Diversified Financial Services | Canada |
First funding | 7/15/2011 | 8/21/1997 | 8/21/1997 | ||
|---|---|---|---|---|---|
Last Funding | 7/15/2011 | 8/21/1997 | 8/21/1997 | ||
Investor | |||||
Rounds | 1 Acquired | 1 Unattributed | 1 Unattributed | ||
Board Seats | Michael Cross | ||||
Type | Corporation | Venture Capital | Venture Capital | Public-Private Partnership | Diversified Financial Services |
Location | Canada | Canada | Canada | Canada | Canada |
gera Therapeutics Acquisitions
1 Acquisition
gera Therapeutics acquired 1 company. Their latest acquisition was LymphoSign on August 09, 2007.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
8/9/2007 | Seed / Angel | $2.9M | Acquired | 1 |
Date | 8/9/2007 |
|---|---|
Investment Stage | Seed / Angel |
Companies | |
Valuation | |
Total Funding | $2.9M |
Note | Acquired |
Sources | 1 |
Compare gera Therapeutics to Competitors
Alice Therapeutics is a biotechnology company.
Athersys develops biotechnology-based therapeutics.
REGiMMUNE is a biotechnology company focused on the discovery, development and commercialization of immune regulatory therapeutics to treat conditions such as allergies, autoimmune diseases and inflammatory disorders.
Raylab is a communication design company with expertise in the biotechnology industry
Catapult is a San Diego-based incubator for biomedical start-ups.
Aurora Biomed is a biotechnology company
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.